Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness.

PURPOSE To evaluate changes in lens opacity in the first year after prophylactic laser peripheral iridotomy (LPI) performed in fellow eyes of subjects with acute primary angle closure (APAC). DESIGN Prospective observational case series. PARTICIPANTS Sixty Asian subjects with unilateral APAC. METHODS All fellow eyes underwent prophylactic LPI within the first week of presentation, followed by 1 week of topical steroids. The degree of lens opacity was graded at the slit-lamp examination using the Lens Opacity Classification System III (LOCS III) with standard color photographs as the reference for grading of lens opacity. This was performed 2 weeks, 4 months, and 12 months after LPI. Progression in lens opacity was defined as an increase in LOCS III grade by 2 or more units in any lens region. MAIN OUTCOME MEASURES Lens Opacity Classification Sytem III grades in nuclear, cortical, and posterior subcapsular (PSC) regions. RESULTS Most patients were Chinese (85%) and female (63.3%), with an average age of 61.5 +/- 10.6 years. The mean baseline LOCS grades in the nuclear, cortical, and PSC regions were 3.58 +/- 0.74, 0.57 +/- 1.08, and 0.23 +/- 0.72, respectively. With 12 months of follow-up, 14 of the 60 eyes (23.3%; 95% confidence interval, 16.9-29.7%) showed significant progression in any lens region. Progression in the nuclear, cortical, and PSC regions was documented in 5%, 6.7%, and 16.7% of cases, respectively. By use of logistic regression, the following factors were not found to be significant for cataract progression in any lens region: age, race, gender, history of hypertension or diabetes, presence of peripheral anterior synechiae or angle width at baseline, and total laser energy delivered. CONCLUSIONS In fellow eyes of APAC, prophylactic LPI is complicated by significant cataract progression, mainly in the posterior subcapsular region. These findings may have implications for the role of prophylactic LPI in the prevention of angle-closure blindness.

[1]  P A CHANDLER,et al.  Narrow-angle glaucoma. , 1952, American journal of ophthalmology.

[2]  H. Quigley.  Long-term follow-up of laser iridotomy. , 1981, Ophthalmology.

[3]  M. Rosner,et al.  Comparison of the effects of argon and neodymium:YAG laser iridotomy on prostaglandin E2 and blood-aqueous barrier disruption. , 1990, Ophthalmic research.

[4]  D. Friedman,et al.  Interventions for angle-closure glaucoma , 2003 .

[5]  A. Robin,et al.  Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Long-term follow-up. , 1982, Archives of ophthalmology.

[6]  M. C. Leske,et al.  Incidence and progression of cortical and posterior subcapsular opacities: the Longitudinal Study of Cataract. The LSC Group. , 1997, Ophthalmology.

[7]  P. Foster,et al.  Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. , 1997, Archives of ophthalmology.

[8]  M. C. Leske,et al.  Incidence and progression of lens opacities in the Barbados Eye Studies. , 2000, Ophthalmology.

[9]  R. Lowe.  The natural history and principles of treatment of primary angle-closure glaucoma. , 1966, American journal of ophthalmology.

[10]  C. Hsiao,et al.  Mid-term follow-up of Nd:YAG laser iridotomy in Asian eyes. , 2003, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[11]  M. C. Leske,et al.  Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. , 2004, Archives of ophthalmology.

[12]  D. Friedman,et al.  Interventions for angle-closure glaucoma: an evidence-based update. , 2003, Ophthalmology.

[13]  J. McAvoy,et al.  Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye. , 1998, Investigative ophthalmology & visual science.

[14]  A. S. Lim,et al.  Comparison of argon laser iridotomy and sequential argon laser and Nd:YAG laser iridotomy in dark irides. , 1996, Ophthalmic surgery and lasers.

[15]  P. Foster,et al.  YAG laser iridotomy treatment for primary angle closure in east Asian eyes , 2000, The British journal of ophthalmology.

[16]  Bernard Becker,et al.  Diagnosis and Therapy of the Glaucomas , 1961 .

[17]  M. Mitchell,et al.  Prostaglandin release following Nd:YAG iridotomy in rabbits. , 1986, Ophthalmic surgery.

[18]  T. Aung,et al.  Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. , 2000, Ophthalmology.

[19]  F. Lovicu,et al.  Peter Bishop Lecture: Growth factors in lens development and cataract: key roles for fibroblast growth factor and TGF‐β , 2000, Clinical & experimental ophthalmology.

[20]  M. C. Leske,et al.  The Lens Opacities Classification System III , 1993 .

[21]  J. McAvoy,et al.  Inhibition of transforming growth factor-beta-induced cataractous changes in lens explants by ocular media and alpha 2-macroglobulin. , 1996, Investigative ophthalmology & visual science.

[22]  Jean-Paul Cristol,et al.  Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Delcourt C* cristol J-P, tessier F, Leger CL, michel F, papoz L, and the POLA study group. Am J epidemiol 2000;151:497-504 , 2000, American journal of ophthalmology.

[23]  M. C. Leske,et al.  Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract. , 1996, Ophthalmology.